Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification

European Journal of Cancer

Volumn 38, Issue 1, 2002, Pages 75-81

  Kim, K ^a   Kim, W S ^a   Jung, C W ^a   Im, Y H ^a   Kang, W K ^a   Lee, M H ^a   Park, C H ^a   Ko, Y H ^a   Ree, H J ^a   Park, K ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

CHOP; International Prognosis Index; Peripheral T cell lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CANCER REGRESSION; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG MECHANISM; DRUG RESPONSE; FEMALE; HISTOLOGY; HUMAN; INTESTINE LYMPHOMA; LARGE CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANNICULITIS; PRIORITY JOURNAL; PROGNOSIS; SKIN LYMPHOMA; STATISTICS; T CELL LYMPHOMA; TREATMENT OUTCOME;

EID: 0036139110     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00344-6     Document Type: Article

References (26)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
2. REAL classification of malignant lymphomas in the Republic of Korea
3. Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the REAL classification
4. Classification of T-cell and NK-cell neoplasms based on the REAL classification
5. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms
6. Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the REAL classification
7. Report of the European Task Force on Lymphomas: Workshop on peripheral T-cell lymphomas
8. Prognostic significance of T-Cell phenotype in aggressive non-Hodgkin's lymphomas
9. Detection of Epstein-Barr virus in Korean peripheral T-cell lymphoma
10. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project
11. Peripheral T-cell and NK-cell neoplasms: An integrated approach to diagnosis
12. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma
13. Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project
14. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma
15. Reporting treatment results in solid tumours
16. Nonparametric estimation from incomplete observations
17. Regression models and life tables
18. Clinicopathologic characteristics of Korean Non-Hodgkin's lymphomas based on REAL classification
19. Extranodal peripheral T-cell and NK-cell neoplasms
20. The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities
21. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma
22. CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?
23. Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas
24. Intensive chemotherapy for peripheral T-cell lymphomas
25. T-cell lymphomas: Immunologic, histologic, clinical, and therapeutic analysis of 63 cases